Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CD40 (human):COMP (human), (recombinant)

First non-antibody blocker of CD40L signalling
ALX-522-064-C010 10 µg 460.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:TNFRSF 5
MW:~36kDa (SDS-PAGE).
Source:Produced in HEK 293 cells. The extracellular domain of human CD40 (aa 1-193) is fused to a FLAG®-tag at the N-terminus and to human cartilage oligomeric matrix protein (COMP, aa 32-80) at the C-terminus.
UniProt ID:P25942
Concentration:0.1mg/ml after reconstitution.
Formulation:Lyophilized. Contains PBS.
Purity:≥90% (SDS-PAGE)
Endotoxin Content:<0.1EU/µg purified protein (LAL test; Bio Whittaker).
Specificity:Binds human CD40L (CD154).
Reconstitution:Reconstitute with 100µl sterile distilled water. Further dilutions should be made with medium containing 5% fetal calf serum or a carrier protein.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Use/Stability:Stable for at least 6 months after receipt when stored at -20°C.
Handling:Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C.
Scientific Background:COMP (Cartilage Oligomeric Matrix Protein) also designated thrombospondin 5 (TSP 5) is an oligomeric protein synthesized by chondrocytes in all type of cartilage. It belongs to the thrombospondin family of extracellular proteins. It is a pentameric molecule forming a structure similar to a bouquet of flowers. It may have storage and delivery function for hydrophobic cell-signalling molecules such as vitamin D.
COMP is a calcium-binding protein composed of 5 identical disulfide-linked subunits of 755 amino acids each with a high percentage of acidic residues (30%). The molecular weight of the homopentamer is 524 kDa, as determined by sedimentation equilibrium ultracentrifugation. Each subunit is composed of an N-terminal coiled-coil domain (unique to COMP), four epidermal growth factor (EGF)-type repeats, followed by eight calmodulin-like repeats and a globular C-terminal domain. The C-terminal domain binds to collagens I, II and IX.
Chimeras composed of proteins fused to the pentamerization domain of COMP (aa 32-75) show an increased avidity compared to the protein alone. Historical results have shown that COMP is a potent blocker of mouse CD40L-dependent B cell proliferation without the requirement of any crosslinking reagent (enhancer).
Technical Info/Product Notes:FLAG is a registered trademark of Sigma-Aldrich Co.
CD40 (human):COMP (human), (recombinant) image

Method: rhCD40-COMP blocks rmsCD40L-induced proliferation of murine B cells. Splenocytes from Balb/c mice were purified on B220 magnetic beads using the MACS system. The resulting B cells were put into culture at a density of 70’000 cells/well in a 96-well plate. 500 ng/ml of rmsCD40L (Prod. No. ALX-522-043) in the presence of 1 mg/ml of enhancer (Prod. No. ALX-804-034) were preincubated for 30 min. at RT with the indicated concentrations of rhCD40-COMP (Prod. No. ALX-522-064) or rhCD40:Fc (Prod. No. ALX-522-016), and then added to the purified B cells. After 36 hours, 0.5mCi of 3H-Thymidine/well was added. Cells were pulsed for 10 hours, freeze-thawed, harvested and counted. Results are expressed as % of inhibition of the maximal proliferation yielded when no rhCD40-COMP or rhCD40:Fc were added.

CD40 (human):COMP (human), (recombinant) Structure
Figure: Domain structure of a COMP subunit (upper figure) and structure of the CD40:COMP chimera (lower figure).
Please mouse over
CD40 (human):COMP (human), (recombinant) image CD40 (human):COMP (human), (recombinant) Structure

Product Literature References

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors: N. Holler, et al.; J. Immunol. Methods 237, 159 (2000), Abstract;

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
CD40 Recombinant protein
By catalog section:


Technical Service
Customer Service

Related Literature

Stem Cells
Stem Cells
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,